Cyclerion Therapeutics (CYCN) Enterprise Value (2019 - 2025)
Cyclerion Therapeutics (CYCN) has 7 years of Enterprise Value data on record, last reported at -$4.6 million in Q3 2025.
- For Q3 2025, Enterprise Value fell 59.05% year-over-year to -$4.6 million; the TTM value through Sep 2025 reached -$4.6 million, down 59.05%, while the annual FY2024 figure was -$3.2 million, 57.31% up from the prior year.
- Enterprise Value reached -$4.6 million in Q3 2025 per CYCN's latest filing, down from -$3.0 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$2.9 million in Q3 2024 and bottomed at -$70.4 million in Q2 2021.
- Average Enterprise Value over 5 years is -$20.6 million, with a median of -$7.6 million recorded in 2023.
- Peak YoY movement for Enterprise Value: soared 82.56% in 2023, then plummeted 59.05% in 2025.
- A 5-year view of Enterprise Value shows it stood at -$54.0 million in 2021, then surged by 75.2% to -$13.4 million in 2022, then surged by 43.42% to -$7.6 million in 2023, then surged by 57.31% to -$3.2 million in 2024, then crashed by 41.34% to -$4.6 million in 2025.
- Per Business Quant database, its latest 3 readings for Enterprise Value were -$4.6 million in Q3 2025, -$3.0 million in Q2 2025, and -$3.6 million in Q1 2025.